华邦健康：预计2025年净利润为6.6亿元-7.3亿元，同比扭亏为盈

Core Viewpoint - The company expects a net profit of 660 million to 730 million yuan for the fiscal year 2025, a significant recovery from a loss of 299 million yuan in the same period last year [1] Group 1: Strategic Focus - The company is committed to its core business and is executing a strategic approach characterized by "cautious expansion, reduced financing, deep market penetration, and strong defenses" [1] - This strategic focus aims to enhance the company's core competitiveness and improve operational management across various business segments [1] Group 2: Business Performance - The agricultural chemical materials segment has shown signs of partial recovery, leading to improved overall performance [1] - The company is actively exploring market opportunities and implementing refined management practices to reduce costs and increase efficiency [1] - The pharmaceutical and tourism segments have also achieved steady growth, contributing to the overall performance improvement of the company [1]